Mirum Pharmaceuticals
MIRM
96.13
+0.62
+0.65%
Mirum Pharmaceuticals
US · MIRM
#2051 by market cap
Listed 2019
96.13
+0.62
+0.65%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 12 analysts
Buy
Avg price target 158.82 +65.2%
Price target rangecurrent 96.13
Low130.00
Avg158.82
High202.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Citi | -- | Buy | 194.00 |
| 2026-11-11 | H.C. Wainwright | -- | Buy | 202.00 |
| 2026-11-10 | Citi | -- | Buy | 194.00 |
| 2026-11-09 | Citi | -- | Buy | 184.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | -- |
| 2026-11-05 | Morgan Stanley | -- | Buy | 152.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 140.00 |
| 2026-11-04 | Citizens JMP | -- | Buy | 167.00 |
| 2026-11-04 | Stifel | -- | Buy | 156.00 |
| 2026-11-04 | H.C. Wainwright | -- | Buy | 202.00 |
| 2026-11-03 | TD Cowen | -- | Buy | 145.00 |
| 2026-11-03 | Cantor Fitzgerald | -- | Buy | 160.00 |
| 2026-11-03 | RBC Capital | -- | Buy | 155.00 |
| 2026-10-27 | H.C. Wainwright | -- | Buy | 200.00 |
| 2026-10-21 | TD Cowen | -- | Buy | 145.00 |
| 2026-10-15 | Stifel | -- | Buy | 156.00 |
| 2026-10-14 | Stifel | -- | Buy | 156.00 |
| 2026-10-13 | Morgan Stanley | -- | Buy | 152.00 |
| 2026-10-13 | Evercore | -- | Buy | 146.00 |
| 2026-10-13 | Citi | -- | Buy | 184.00 |
| 2026-10-12 | Morgan Stanley | -- | Buy | 152.00 |
| 2026-10-12 | Citi | -- | Buy | 184.00 |
| 2026-10-12 | H.C. Wainwright | -- | Buy | 200.00 |
| 2026-10-12 | J.P. Morgan | -- | Buy | -- |
| 2026-10-08 | H.C. Wainwright | -- | Buy | 195.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-03 | After close | ±10.62% | +11.42% (beat) |
| 2026/Q2 | 2026-08-05 | After close | ±9.27% | -11.04% (beat) |
| 2026/Q1 | 2026-05-06 | After close | ±6.10% | -6.50% (beat) |
| 2025/Q4 | 2026-02-25 | After close | ±8.08% | -15.13% (beat) |
| 2025/Q3 | 2025-11-04 | After close | ±9.62% | -1.24% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±9.40% | +12.04% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±8.61% | +9.75% (beat) |
| 2024/Q4 | 2025-02-26 | After close | ±12.69% | -7.02% (in line) |
| 2024/Q3 | 2024-11-12 | -- | -- | +1.61% |
| 2024/Q2 | 2024-08-07 | After close | ±14.68% | +2.34% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±8.59% | +3.16% (in line) |
| 2023/Q4 | 2024-02-28 | After close | ±20.04% | -0.62% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mirum Pharmaceuticals discussion 0 comments